Shilpa Gupta

26PUBLICATIONS
233CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 05, 2026
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.

|Jul 27, 2026
Antibody Drug Conjugates in Urothelial Carcinoma: Current Evidence and Practice Considerations.

|Feb 27, 2026
A small-molecule inverse agonist of PPARγ for advanced solid tumors: a phase 1 trial.

Matthew D Galsky, Charlene Mantia, Michaela Bowden

|Dec 01, 2025
A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer.

Sebastian Medina, Naoto Tokuyama, Kamal Hammouda

|Nov 20, 2025
Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.

Deaglan McHugh, Matthew Dallos, Min Yuen Teo

|Oct 01, 2025
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study.

Amanda Nizam, Charles B Nguyen, Jinju Li

Pageof 5

Frequent Collaborators

5 joint publications

Ashish M Kamat

5 joint publications

Petros Grivas

5 joint publications

Peter C Black

4 joint publications

Matthew D Galsky